Cellino is using AI and machine learning to scale production of stem cell therapies
TechCrunch
SEPTEMBER 22, 2021
technology, machine learning, hardware, software — and yes, lasers! Founded by a team whose backgrounds include physics, stem cell biology, and machine learning, Cellino operates in the regenerative medicine industry. — could eventually democratize access to cell therapies.
Let's personalize your content